1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Alternative Plants

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2015

Location

Riga Latvia

Primary Industry

Biotechnology

About

Based in Riga, Latvia, and founded in 2015 by its CEO Anna Ramata-Stunda, and CTO Martins Boroduskis, Alternative Plants Ltd. operates as a biotechnology company specializing in the development of bioactive ingredients sourced from medicinal plants. In May 2022, Alternative Plants raised EUR 0.50 million in seed funding from SOSV, Givaldi and Buildit Accelerator.  Alternative Plants Ltd. specializes in bioactive ingredients such as silvacell is a blend of juniper stem cells infused with potent antimicrobial compounds from lichens; and JuniCell resulting in anti-aging and skin-protecting properties. Additionally, the company offers septocone, and dragoncell derived from the stem cells of Northern Dragonhead, and provides high antioxidative and skin-regenerating activity.
Current Investors
SOSV, Buildit Accelerator, Givaldi

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Consulting Services, Beauty & Hygiene, Pharmaceutical Research & Development
Website
www.alternativeplants.eu
Verticals
Manufacturing
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.